Emily M. Leproust, Chief Executive Officer at Twist Bioscience Corp (TWST), sold 113,318 shares at $125.16 ($14.2M) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Scheduled sale ($14.2M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TWST | SELL | 2026-09-25 | $923K | — | Filing → |
| TWST | SELL | 2026-09-23 | $279K | — | Filing → |
| TWST | SELL | 2026-09-21 | $56.3M | — | Filing → |